Tulip Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 25-12-2024
- Paid Up Capital ₹ 2.16 Cr
as on 25-12-2024
- Company Age 36 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.73 Cr
as on 25-12-2024
- Revenue 21.23%
(FY 2022)
- Profit -28.37%
(FY 2022)
- Ebitda -20.77%
(FY 2022)
- Net Worth 515.11%
(FY 2022)
- Total Assets 4.18%
(FY 2022)
About Tulip Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 2.16 Cr.
The company has closed loans amounting to ₹2.73 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Deepak Tripathi, Alok Kumar, and Narendra Makkar serve as directors at the Company.
- CIN/LLPIN
U85195GA1988PTC005717
- Company No.
005717
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Tulip Diagnostics Private Limited offer?
Tulip Diagnostics Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, Analyzers & Analytical Instruments, Digital Analyzers, Dust Samplers, Air Samplers, IVDs & Analyzers, Elemental Analyzer, Biochemistry Analyzer, Chemistry Analyzers.
Who are the key members and board of directors at Tulip Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Tripathi  | Director | 05-May-2017 | Current |
| Alok Kumar | Director | 31-Jan-2017 | Current |
Narendra Makkar  | Director | 19-Sep-2017 | Current |
Financial Performance of Tulip Diagnostics.
Tulip Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.23% increase. The company also saw a substantial fall in profitability, with a 28.37% decrease in profit. The company's net worth Soared by an impressive increase of 515.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tulip Diagnostics?
In 2022, Tulip Diagnostics had a public holding of 100.00%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biosense Technologies Private LimitedActive 16 years 1 monthDeepak Tripathi, Alok Kumar and 1 more are mutual person
Orchid Biomedical Systems Private LimitedActive 34 years 10 monthsDeepak Tripathi, Alok Kumar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 23 Oct 2003 | ₹9.50 M | Satisfied |
Bank Of India Creation Date: 17 Apr 1999 | ₹1.50 M | Satisfied |
Bank Of India Creation Date: 12 Mar 1993 | ₹1.00 M | Satisfied |
How Many Employees Work at Tulip Diagnostics?
Tulip Diagnostics has a workforce of 1416 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tulip Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tulip Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
